Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

A conformal array of flexible electrodes affixed to an inflated balloon catheter. The sensors have the ability to make measurements of temperature, force of contact and electrophysiological parameters, ability to customize diagnostic and therapeutic functions and offer real-time feedback. Photo by John Rogers, Northwestern University.
News | EP Lab
Flexible Electronics Mounted on Balloons May Improve Cardiac Catheter Ablation Procedures 

September 8, 2020 — Researchers developed a new class of medical instruments equipped with an advanced soft electronics ...

Home September 08, 2020
Home
The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the Boston Scientific Eluvia Drug-Eluting Vascular Stent System as part of the 2021 Inpatient Prospective Payment System (IPPS). 
News | Peripheral Artery Disease (PAD)
CMS Grants Additional Reimbursement for Eluvia Vascular Stent

September 4, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment ...

Home September 04, 2020
Home
Abbott Espirit BTK Bioresorbable stent, or bioresorbable vascular scaffold (BVS) measures 99 microns and is made from poly-L-lactide (PLLA), a semi-crystalline bioresorbable polymer engineered to resist vessel recoil and provide a platform for drug delivery. Abbott Absorb
Feature | Stents Bioresorbable
Abbott Restarts Bioresorbable Stent Clinical Trials With New Esprit Below-the-knee Scaffold

September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...

Home September 03, 2020
Home
Tailor PCI trial showed genetic testing may play a role in personalizing antiplatelet therapy after PCI.
News | Antiplatelet and Anticoagulation Therapies
Trial Shows Benefit of Using Genetic Testing to Tailor Antiplatelet Therapy 

September 2, 2020 — An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by ...

Home September 02, 2020
Home
Videos | TCT
VIDEO: What to Expect at the Virtual TCT 2020 Meeting

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

Home August 01, 2020
Home
The Morristown Medical Center radial lounge uses recliner chairs rather than hospital beds for patients recovering from cath lab procedures using transradial access. The vascular access technique allows patients to immediately walk off the cath lab table following a procedure and they can use the bathroom and walk around during recovery. This is rapidly becoming the preferred access route in cath labs as opposed to the long-used standard of care of femoral artery access in the groin. #transradial
News | Radial Access
Atlantic Health Morristown Medical Center Opens Radial Lounge for Post-procedure Recovery

August 25, 2020 – Atlantic Health System’s Morristown Medical Center has opened one of the region’s first radial lounges ...

Home August 25, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor
Cardiovascular Innovation at Tufts Medical Center

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
Boston Scientific recently introduced the newst iteration of LAA occluder device, the Watchman FLX. It uses small spikes to help better anchor the device and prevent embolization.
News | Left Atrial Appendage (LAA) Occluders
COVID-19 Boosts Demand for Left Atrial Appendage Closure Devices Market

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
The Philips Healthcare OmniWire is the world’s first solid core fractional flow reserve (FFR) pressure wire for coronary artery interventional procedures.
News | FFR Technologies
Philips Introduces First Solid Core Pressure Guidewire for Coronary Interventional Procedures

August 18, 2020 — Philips Healthcare introduced its new OmniWire, the world’s first solid core fractional flow reserve ...

Home August 18, 2020
Home
An example of the 3-D vascular roadmapping technology on the Ziehm mobile C-arm systems.
News | Mobile C-Arms
Ziehm Imaging Acquires French Imaging Software Developer Therenva

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Home August 18, 2020
Home
Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.
News | Vascular Closure Devices
Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.

August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure ...

Home August 17, 2020
Home
The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.
News | Congenital Heart
Smidt Heart Institute Enhances Congenital Heart Program to Follow Patients as Neonates Through Adulthood

August 10, 2020 - The Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai is expanding ...

Home August 10, 2020
Home
The Conformal Medical CLAAS device, a next-generation transcatheter left atrial appendage (LAA) closure occluder for patients with atrial fibrillation (AF). LAA occlusion allows AFib patients to go off of life-long anticoagulation therapy. #LAA #LAAC
News | Left Atrial Appendage (LAA) Occluders
Conformal Medical Secures $85 Million in Funding for Left Atrial Appendage Occluder Trial

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Allows Emergency Use of Impella for COVID-19 Patients on ECMO

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for ...

Home August 05, 2020
Home
Large Study in Japan Finds High Survival Rates With Impella Heart Pump
News | Cardiogenic Shock
Large Study in Japan Finds High Survival Rates With Impella Heart Pump

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

Home August 03, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now